These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach. Velosa A; Neves A; Barahona-Corrêa JB; Oliveira-Maia AJ BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31213433 [TBL] [Abstract][Full Text] [Related]
44. Severe catatonia and neuroleptic malignant syndrome: report of 3 cases. Kasantikul D; Kanchananakhin P J Med Assoc Thai; 1999 Sep; 82(9):942-6. PubMed ID: 10561954 [TBL] [Abstract][Full Text] [Related]
45. [The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam]. Real Rodríguez B; Ruibal JL; Grande Rodríguez S; Sueiro Pita B An Esp Pediatr; 1996 Jan; 44(1):60-2. PubMed ID: 8849063 [No Abstract] [Full Text] [Related]
47. [Neuroleptic malignant syndrome: a life-threatening complication that can be treated effectively]. Rondeel JM Ned Tijdschr Geneeskd; 2007 Jan; 151(2):154; author reply 154-5. PubMed ID: 17315497 [No Abstract] [Full Text] [Related]
48. Residual catatonic state following neuroleptic malignant syndrome. Caroff SN; Mann SC; Keck PE; Francis A J Clin Psychopharmacol; 2000 Apr; 20(2):257-9. PubMed ID: 10770467 [TBL] [Abstract][Full Text] [Related]
49. Malignant catatonia-induced respiratory failure with response to ECT. Boyarsky BK; Fuller M; Early T J ECT; 1999 Sep; 15(3):232-6. PubMed ID: 10492863 [TBL] [Abstract][Full Text] [Related]
50. Neuroleptic malignant syndrome from central nervous system insult: 4 cases and a novel treatment strategy. Clinical article. Wait SD; Ponce FA; Killory BD; Wallace D; Rekate HL J Neurosurg Pediatr; 2009 Sep; 4(3):217-21. PubMed ID: 19772404 [TBL] [Abstract][Full Text] [Related]
51. Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases. Harsch HH J Clin Psychiatry; 1987 Aug; 48(8):328-33. PubMed ID: 2886491 [TBL] [Abstract][Full Text] [Related]
54. ECT treatment of malignant catatonia/NMS in an adolescent: a useful lesson in delayed diagnosis and treatment. Ghaziuddin N; Alkhouri I; Champine D; Quinlan P; Fluent T; Ghaziuddin M J ECT; 2002 Jun; 18(2):95-8. PubMed ID: 12195138 [TBL] [Abstract][Full Text] [Related]
55. [Neuroleptic malignant syndrome associated with the inadequate antidiuretic hormone secretion syndrome]. García Escrig M; Bermejo Pareja F; Soto Téllez O; Díaz Guzmán J; Lledó A Arch Neurobiol (Madr); 1992; 55(2):75-8. PubMed ID: 1352098 [TBL] [Abstract][Full Text] [Related]
56. Are neuroleptic malignant syndrome and serotonin syndrome the same syndrome? Steele D; Keltner NL; McGuiness TM Perspect Psychiatr Care; 2011 Jan; 47(1):58-62. PubMed ID: 21418073 [No Abstract] [Full Text] [Related]
57. [What do we know today about neuroleptic malignant syndrome?]. Nyquist OG Tidsskr Nor Laegeforen; 1996 Oct; 116(24):2879-82. PubMed ID: 8975402 [TBL] [Abstract][Full Text] [Related]
58. A Severe Neuroleptic Malignant Syndrome Treated with Daily Electroconvulsive Therapy: A Case Report. Aki ÖE; Gürcan A; Gürel ŞC; Yazici MK Turk Psikiyatri Derg; 2022; 33(2):139-142. PubMed ID: 35730514 [TBL] [Abstract][Full Text] [Related]
60. A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review. Chiou YJ; Lee Y; Lin CC; Huang TL Medicine (Baltimore); 2015 Oct; 94(43):e1752. PubMed ID: 26512569 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]